keyword
https://read.qxmd.com/read/38712049/mild-hyperthermia-enhanced-liposomal-doxorubicin-delivery-and-cd8-t-cell-infiltration-in-triple-negative-breast-cancer
#21
Farzaneh Rezazadeh, Wajfa Saadat, Ryan Smith, Alexander Pattyn, Mohammad Malik, Fuad Yazdani, Allen-Dexter Saliganan, Mohammad Mehrmohammadi, Nerissa T Viola
Mild hyperthermia (MHTh) is often used in combination with chemotherapy and radiotherapy for cancer treatment. In the current study, the effect of MHTh on the enhanced uptake of the FDA-approved chemotherapy drug, liposomal doxorubicin (dox) in syngeneic 4T1 tumors was investigated. Doxorubicin has inherent fluorescence properties having an emission signal at 590 nm upon excitation with a 480 nm laser. A group of mice administered with doxorubicin (dox) were exposed to MHTh (42 °C) for 30 minutes whereas control group given dox did not receive MHTh...
April 27, 2024: bioRxiv
https://read.qxmd.com/read/38712038/development-of-quantitative-high-throughput-screening-assays-to-identify-validate-and-optimize-small-molecule-stabilizers-of-misfolded-%C3%AE-glucocerebrosidase-with-therapeutic-potential-for-gaucher-disease-and-parkinson-s-disease
#22
Darian Williams, Logan M Glasstetter, Tiffany T Jong, Abhijeet Kapoor, Sha Zhu, Yanping Zhu, Alexandra Gehrlein, David J Vocadlo, Ravi Jagasia, Juan J Marugan, Ellen Sidransky, Mark J Henderson, Yu Chen
UNLABELLED: Glucocerebrosidase (GCase) is implicated in both a rare, monogenic disorder (Gaucher disease, GD) and a common, multifactorial condition (Parkinson's disease); hence, it is an urgent therapeutic target. To identify correctors of severe protein misfolding and trafficking obstruction manifested by the pathogenic L444P-variant of GCase, we developed a suite of quantitative, high-throughput, cell-based assays. First, we labeled GCase with a small pro-luminescent HiBiT peptide reporter tag, enabling quantitation of protein stabilization in cells while faithfully maintaining target biology...
March 27, 2024: bioRxiv
https://read.qxmd.com/read/38711896/advanced-gallbladder-cancer-with-high-tumor-mutation-burden-a-case-report-and-literature-review
#23
Juan Wang, Jianmin Liu, Chao Yan, Kai Wang, Qiuyao Li, Jie Yu
BACKGROUND: Gallbladder cancer (GBC) is a common malignant tumor of the biliary system. It is characterised by insidious onset, rapid progression and poor prognosis. Symptoms often indicate advanced or late-stage disease, with a 5-year survival rate of only 5-15%. CASE DESCRIPTION: We present a case study of a patient with GBC who had a tumor mutation burden (TMB) of 32.5/MB (≥10 muts/MB). The patient received mFOLFIRINOX as first-line chemotherapy, which demonstrated significant efficacy...
2024: AME Case Reports
https://read.qxmd.com/read/38711893/partial-response-to-crizotinib-regorafenib-pd-1-inhibitor-in-a-metastatic-braf-v600emt-colon-cancer-patient-with-acquired-c-met-amplification-and-tpm4-alk-fusion-a-case-report
#24
Yingying Huang, Shuai Zhang, Xueqing Hu, Xiangyang Wang, Yunbo Zhao, Zhongkang Li
BACKGROUND: Colorectal cancer (CRC) with the Raf murine sarcoma viral oncogene homolog B ( BRAF ) V600E had a relatively poor prognosis. Anaplastic lymphoma kinase ( ALK ) fusion and the mesenchymal-to-epithelial transition factor ( MET ) amplification have been recognized as potentially important therapeutic targets in non-small cell lung cancer (NSCLC). However, both of them are of extremely lower frequencies (<2%) in metastatic CRC, and few studies have mentioned the real application of their inhibitors in CRC treatment...
2024: AME Case Reports
https://read.qxmd.com/read/38711822/using-three-dimensional-model-based-tumour-volume-change-to-predict-the-symptom-improvement-in-patients-with-renal-cell-cancer
#25
JOURNAL ARTICLE
ChengWei Fu, JinKai Dong, JingYun Zhang, XueChao Li, ShiDong Zuo, HongTao Zhang, Shen Gao, LiJun Chen
In our recent study, we explored the efficacy of three-dimensional (3D) measurement of tumor volume in predicting the improvement of quality of life (QoL) in patients suffering from renal cell cancer (RCC), who were treated with axitinib and anti-PD-L1 antibodies. This study encompassed 18 RCC patients, including 10 men and 8 women, with an average age of 56.83 ± 9.94 years. By utilizing 3D Slicer software, we analyzed pre- and post-treatment CT scans to assess changes in tumor volume...
May 2024: 3 Biotech
https://read.qxmd.com/read/38711784/endocrine-system-related-adverse-events-associated-with-pd-1-pd-l1-inhibitors-data-mining-from-the-fda-adverse-event-reporting-system
#26
JOURNAL ARTICLE
Hongxia Shi, Yunhua He, Siyuan Dan, Lin Yang, Jing Wang, Li Chen, Zelian Chen
BACKGROUND: Various immune checkpoint inhibitors, such as programmed cell death protein-1 (PD-1) and its ligand (PD-L1), have been approved for use, but they have side effects on the endocrine glands. METHODS: Adverse event reports related to PD-1/PD-L1 inhibitors from the FDA Adverse Event Reporting System (FAERS) from the first quarter of 2019 to the first quarter of 2023 were extracted, and the reported Odds ratio methods (ROR method) and comprehensive standard methods (MHRA methods) were used for data mining and analysis...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38711763/overindebtedness-unemployment-and-poor-mental-health-and-the-role-of-sense-of-control-a-population-based-swiss-study
#27
JOURNAL ARTICLE
Oliver Hämmig
BACKGROUND: Both overindebtedness and unemployment are critical life events that can result in or lead to poor mental health. What is less known is that the two partly interrelated events frequently go along with a feeling of loss or lack of control in life, which could be the main reason why they are associated with poor mental health. This has not been examined in previous research, particularly not in this combination. METHODS: This study used and merged two cross-sectional data sets...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38711682/unconventional-diagnosis-of-bradyarrhythmic-syncope-in-brugada-syndrome-a-case-report
#28
Francesca Esposito, Felice Nappi, Francesco Urraro, Paolo Vitillo, Francesco Rotondi
BACKGROUND: The Brugada syndrome (BrS) is an inherited disorder associated with the risk of ventricular fibrillation and sudden cardiac death (SCD). The current main therapy is an implantable cardioverter-defibrillator (ICD). However, the risk stratification and management of patients remain challenging. Here, we present a case of BrS representative of the pitfalls that clinicians may encounter in the management of Brugada patients in routine clinical practice. CASE SUMMARY: A 39-year-old man with BrS and recurring syncope was implanted with a subcutaneous ICD (S-ICD) (EMBLEM MRI S-ICD, Boston Scientific)...
May 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38711597/detection-of-elevated-levels-of-pink1-in-plasma-from-patients-with-idiopathic-parkinson-s-disease
#29
JOURNAL ARTICLE
Xianchai Hong, Yi Zheng, Jialong Hou, Tao Jiang, Yao Lu, Wenwen Wang, Shuoting Zhou, Qianqian Ye, Chenglong Xie, Jia Li
BACKGROUNDS: Numerous lines of evidence support the intricate interplay between Parkinson's disease (PD) and the PINK1-dependent mitophagy process. This study aimed to evaluate differences in plasma PINK1 levels among idiopathic PD, PD syndromes (PDs), and healthy controls. METHODS: A total of 354 participants were included, consisting of 197 PD patients, 50 PDs patients, and 107 healthy controls were divided into two cohorts, namely the modeling cohort (cohort 1) and the validated cohort (cohort 2)...
2024: Frontiers in Aging Neuroscience
https://read.qxmd.com/read/38711524/the-c1q-and-gc1qr-axis-as-a-novel-checkpoint-inhibitor-in-cancer
#30
REVIEW
Berhane Ghebrehiwet, Michal Zaniewski, Audrey Fernandez, Mathew DiGiovanni, Tiana N Reyes, Ping Ji, Anne G Savitt, Jennie L Williams, Markus A Seeliger, Ellinor I B Peerschke
Understanding at the molecular level of the cell biology of tumors has led to significant treatment advances in the past. Despite such advances however, development of therapy resistance and tumor recurrence are still unresolved major challenges. This therefore underscores the need to identify novel tumor targets and develop corresponding therapies to supplement existing biologic and cytotoxic approaches so that a deeper and more sustained treatment responses could be achieved. The complement system is emerging as a potential novel target for cancer therapy...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38711384/incidence-and-survival-of-primary-metastatic-breast-cancer-in-denmark-implication-of-breast-cancer-screening-classification-and-staging-practice
#31
JOURNAL ARTICLE
Tobias Berg, Maj-Britt Jensen, Maria Rossing, Christian T Axelsen, Iben Kümler, Lise Søndergaard, Marianne Vogsen, Ann S Knoop, Bent Ejlertsen
BACKGROUND: Primary metastatic breast cancer (pMBC) accounts for 5-10% of annual breast cancers with a median survival of 3-4 years, varying among subtypes. In Denmark, the incidence of breast cancer increased until 2010, followed by a stabilisation. Several factors influencing pMBC incidence and survival, including screening prevalence, staging methods, and classification standards, remain pivotal but inadequately documented. MATERIAL AND METHOD: This retrospective observational study involving pMBC patients diagnosed between 2000 and 2020 encompassed all Danish oncology departments...
May 6, 2024: Acta Oncologica
https://read.qxmd.com/read/38711203/pi3k-mtor-inhibition-induces-tumour-microenvironment-remodelling-and-sensitises-ps6-high-uterine-leiomyosarcoma-to-pd-1-blockade
#32
JOURNAL ARTICLE
Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts, Julie Messiaen, Asier Antoranz, Gautam Shankar, Nikolina Dubroja, Alejandro Herreros-Pomares, Regina E M Baiden-Amissah, Marie-Pauline Orban, Marcello Delfini, Emanuele Berardi, Thomas Van Brussel, Rogier Schepers, Gino Philips, Bram Boeckx, Maria Francesca Baietti, Luigi Congedo, Kiave Yune HoWangYin, Emilie Bayon, Anne-Sophie Van Rompuy, Eleonora Leucci, Sebastien P Tabruyn, Francesca Bosisio, Massimiliano Mazzone, Diether Lambrechts, Frédéric Amant
BACKGROUND: Uterine leiomyosarcomas (uLMS) are aggressive tumours with poor prognosis and limited treatment options. Although immune checkpoint blockade (ICB) has proven effective in some 'challenging-to-treat' cancers, clinical trials showed that uLMS do not respond to ICB. Emerging evidence suggests that aberrant PI3K/mTOR signalling can drive resistance to ICB. We therefore explored the relevance of the PI3K/mTOR pathway for ICB treatment in uLMS and explored pharmacological inhibition of this pathway to sensitise these tumours to ICB...
May 2024: Clinical and Translational Medicine
https://read.qxmd.com/read/38711152/support-after-return-to-alcohol-use-a-mixed-methods-study-on-how-abstinence-motivation-and-app-use-change-after-return-to-alcohol-use-in-an-app-based-aftercare-intervention-for-individuals-with-alcohol-use-disorder
#33
RANDOMIZED CONTROLLED TRIAL
Catharina Lang, Kiona K Weisel, Sebastian Saur, Lukas M Fuhrmann, Antonie Schoenleber, Daniela Reichl, Niklas Enewoldsen, Sabine Steins-Loeber, Matthias Berking
BACKGROUND: As the return to alcohol use in individuals with alcohol use disorder (AUD) is common during treatment and recovery, it is important that abstinence motivation is maintained after such critical incidences. Our study aims to explore how individuals with AUD participating in an app-based intervention with telephone coaching after inpatient treatment perceived their abstinence motivation after the return to alcohol use, whether their app use behavior was affected and to identify helpful factors to maintain abstinence motivation...
May 6, 2024: Addiction Science & Clinical Practice
https://read.qxmd.com/read/38711137/-recovery-activities-are-needed-every-step-of-the-way-exploring-the-process-of-long-term-recovery-in-people-previously-diagnosed-with-exhaustion-disorder
#34
JOURNAL ARTICLE
Ingela Aronsson, Anna Stigsdotter Neely, Carl-Johan Boraxbekk, Therese Eskilsson, Hanna M Gavelin
BACKGROUND: Sick-leave rates are high due to stress-related illnesses, but little is still known about the process of recovery from these conditions. The aim of this study was to explore the experiences of the recovery process, 6 to 10 years after treatment in people previously diagnosed with exhaustion disorder (ED), focusing on facilitators and barriers for the process of recovery from ED, and recovery activities experienced as helpful during the recovery process. METHOD: Thirty-eight participants (average age: 52 years, 32 females) previously diagnosed with ED were interviewed with semi-structured interviews 6-10 years after undergoing treatment...
May 6, 2024: BMC Psychology
https://read.qxmd.com/read/38711111/prognostic-potentials-of-ai-in-ophthalmology-systemic-disease-forecasting-via-retinal-imaging
#35
REVIEW
Yong Yu Tan, Hyun Goo Kang, Chan Joo Lee, Sung Soo Kim, Sungha Park, Sahil Thakur, Zhi Da Soh, Yunnie Cho, Qingsheng Peng, Yih-Chung Tham, Tyler Hyungtaek Rim, Ching-Yu Cheng
BACKGROUND: Artificial intelligence (AI) that utilizes deep learning (DL) has potential for systemic disease prediction using retinal imaging. The retina's unique features enable non-invasive visualization of the central nervous system and microvascular circulation, aiding early detection and personalized treatment plans for personalized care. This review explores the value of retinal assessment, AI-based retinal biomarkers, and the importance of longitudinal prediction models in personalized care...
May 6, 2024: Eye and Vision (London, England)
https://read.qxmd.com/read/38711108/a-qualitative-study-of-experiences-with-physical-activity-among-people-receiving-opioid-agonist-therapy
#36
JOURNAL ARTICLE
Einar Furulund, Siv-Elin Leirvåg Carlsen, Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Lars T Fadnes, Torgeir Gilje Lid
BACKGROUND: Physical or mental health comorbidities are common among people with substance use disorders undergoing opioid agonist therapy. As both a preventive and treatment strategy, exercise offers various health benefits for several conditions. Exercise interventions to people with substance use disorders receiving opioid agonist therapy are limited. This study aims to explore experiences with physical activity, perceived barriers, and facilitators among people receiving opioid agonist therapy...
May 6, 2024: Substance Abuse Treatment, Prevention, and Policy
https://read.qxmd.com/read/38711095/efficacy-and-safety-of-hepatic-arterial-infusion-chemotherapy-combined-with-lenvatinib-and-pd-1-inhibitors-for-advanced-hepatocellular-carcinoma-with-macrovascular-invasion
#37
JOURNAL ARTICLE
Yufeng Zhang, Haiyan Zhang, Haoqian Xu, Ying Wang, Long Feng, Fengming Yi
BACKGROUND AND AIMS: The prognosis of hepatocellular carcinoma (HCC) with macrovascular invasion(MaVI)is poor, and the treatment is limited. This study aims to explore the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC), combined with lenvatinib and programmed cell death-1(PD-1) inhibitor in the first-line treatment of HCC with MaVI. METHODS: From July 2020 to February 2022, we retrospectively analyzed consecutive patients with HCC with MaVI who received hepatic arterial infusion FOLFOX(oxaliplatin, 5-fluorouracil, and leucovorin)combined with lenvatinib and PD-1 inhibitor...
May 6, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38711085/engineering-pd-1-targeted-small-protein-variants-for-in-vitro-diagnostics-and-in-vivo-pet-imaging
#38
JOURNAL ARTICLE
Joanna Maria Mierzwicka, Hana Petroková, Leona Rašková Kafková, Petr Kosztyu, Jiří Černý, Milan Kuchař, Miloš Petřík, Kateřina Bendová, Kristýna Krasulová, Yaroslava Groza, Lucie Vaňková, Shiv Bharadwaj, Natalya Panova, Michal Křupka, Jozef Škarda, Milan Raška, Petr Malý
BACKGROUND: Programmed cell death 1 (PD-1) belongs to immune checkpoint proteins ensuring negative regulation of the immune response. In non-small cell lung cancer (NSCLC), the sensitivity to treatment with anti-PD-1 therapeutics, and its efficacy, mostly correlated with the increase of tumor infiltrating PD-1+ lymphocytes. Due to solid tumor heterogeneity of PD-1+ populations, novel low molecular weight anti-PD-1 high-affinity diagnostic probes can increase the reliability of expression profiling of PD-1+ tumor infiltrating lymphocytes (TILs) in tumor tissue biopsies and in vivo mapping efficiency using immune-PET imaging...
May 6, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38711032/association-between-physical-activity-changes-and-incident-myocardial-infarction-after-ischemic-stroke-a-nationwide-population-based-study
#39
JOURNAL ARTICLE
Dae Young Cheon, Kyung do Han, Yeon Jung Lee, Jeen Hwa Lee, Myung Soo Park, Do Young Kim, Jae Hyuk Choi, Sook Jin Lee, Kyung-Ho Yu, Seongwoo Han, Sunki Lee, Minwoo Lee
BACKGROUND: The impact of changes in physical activity after ischemic stroke (IS) on the subsequent myocardial infarction (MI) risk is not fully understood. We aimed to investigate the effects of changes in physical activity on the risk of MI after acute IS using data from the Korean National Health Insurance Services Database. METHODS: 224,764 patients newly diagnosed with IS between 2010 and 2016 who underwent two serial biannual health checkups were included...
May 6, 2024: BMC Public Health
https://read.qxmd.com/read/38710915/exploring-cognitive-reserve-s-influence-unveiling-the-dynamics-of-digital-telerehabilitation-in-parkinson-s-disease-resilience
#40
JOURNAL ARTICLE
Sara Isernia, Sonia Di Tella, Federica Rossetto, Francesca Borgnis, Olivia Realdon, Monia Cabinio, Chiara Pagliari, Alessandro Torchio, Anna Castagna, Valeria Blasi, Maria Caterina Silveri, Francesca Baglio
Telerehabilitation is emerging as a promising digital method for delivering rehabilitation to Parkinson's Disease (PD) patients, especially in the early stages to promote brain resilience. This study explores how cognitive reserve (CR), the brain's ability to withstand aging and disease, impacts the effectiveness of telerehabilitation. It specifically examines the influence of lifelong cognitive activities on the relationship between neural reserve and improved functional abilities following rehabilitation...
May 6, 2024: NPJ Digital Medicine
keyword
keyword
79724
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.